Results 21 to 30 of about 10,710,575 (236)

Breast asymmetry and predisposition to breast cancer [PDF]

open access: yes, 2006
Introduction It has been shown in our previous work that breast asymmetry is related to several of the known risk factors for breast cancer, and that patients with diagnosed breast cancer have more breast volume asymmetry, as measured from mammograms ...
Lancaster, Gillian   +2 more
core   +6 more sources

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

open access: yesCa, 2021
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
Hyuna Sung   +6 more
semanticscholar   +1 more source

Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress [PDF]

open access: yes, 2017
We, the Korean Breast Cancer Society (KBCS), present the facts and the trends of breast cancer in Korea in 2014. Data on the total number of newly diagnosed patients was obtained from the Korea Central Cancer Registry database, other data were collected ...
박병우   +13 more
core   +2 more sources

Triple-negative breast cancer molecular subtyping and treatment progress

open access: yesBreast Cancer Research, 2020
Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2), has clinical features that include high invasiveness,
Li Yin   +3 more
semanticscholar   +1 more source

Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives

open access: yesBreast Cancer, 2023
Breast cancer is the most commonly diagnosed cancer and the leading cause of death among female patients, which seriously threatens the health of women in the whole world.
Jun Wang, San-Gang Wu
semanticscholar   +1 more source

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

open access: yesThe Lancet, 2014
BACKGROUND Pathological complete response has been proposed as a surrogate endpoint for prediction of long-term clinical benefit, such as disease-free survival, event-free survival (EFS), and overall survival (OS).
P. Cortazar   +36 more
semanticscholar   +1 more source

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

open access: yes, 2007
Association studies in large series of breast cancer patients can be used to identify single-nucleotide polymorphisms (SNP) contributing to breast cancer susceptibility.
Pharoah, Paul DP   +22 more
core   +1 more source

The Policy Proposal for Effective Prevention and Management of Breast Cancer [PDF]

open access: yes, 2006
Breast cancer is the most common cancer in Korean women since 2001 and needs national interests. The incidence of breast cancer is increasing with new breast cancer cases reaching more than 10,000 cases annually.
정준   +10 more
core   +1 more source

Targeting HER2-positive breast cancer: advances and future directions

open access: yesNature reviews. Drug discovery, 2022
The discovery of the monoclonal antibody trastuzumab almost 25 years ago revolutionized treatment and drug development for HER2^+ breast cancer. Here, Swain et al.
S. Swain, M. Shastry, E. Hamilton
semanticscholar   +1 more source

Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. [PDF]

open access: yes, 2010
BACKGROUND: Truncating mutations in ATM have been shown to increase the risk of breast cancer but the effect of missense variants remains contentious.
Schürmann, Peter   +416 more
core   +1 more source

Home - About - Disclaimer - Privacy